Stakeholders' views on the use of psychotropic medication in older people: a systematic review
- PMID: 35305087
- PMCID: PMC8934150
- DOI: 10.1093/ageing/afac060
Stakeholders' views on the use of psychotropic medication in older people: a systematic review
Abstract
Background: psychotropic medication use has been shown to increase with age and has been associated with increased risk of falls, strokes and mortality. Various guidelines, regulations and tools have been developed to reduce inappropriate prescribing, but this remains high. In order to understand the reasons for this, we aimed to systematically review healthcare professionals', patients' and family caregivers' attitudes towards the use of psychotropic medication in older people.
Methods: a systematic literature search was carried out from inception to September 2020 using PUBMED, EMBASE, PsycINFO and CINAHL and hand-searching of reference lists. Included studies investigated stakeholder views on psychotropic in adults over the age of 65. Findings were thematically synthesised.
Results: overall, there was an acceptance of long-term psychotropic medication for older people both living in the community and in residential care. While healthcare professionals were aware of guidelines for the use of benzodiazepines and psychotropic medicines, they identified barriers to following them on individual, team and organisational levels. Alternative non-pharmacological approaches were not always available or accepted by patients.
Conclusion: psychotropic medicine use in older adults remains a complex issue, which needs to be addressed on a broad level. Attitudes of older people and healthcare professionals encourage long-term use. Meanwhile, various internal and external factors act as barriers to the use of non-drug alternatives in this population. In order to reduce overprescribing of psychotropics, there is a need to increase the acceptability and accessibility of alternative interventions in both care homes and the community.
Keywords: professional and patient/lay perspectives; psychotropic medication; qualitative.
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Figures
Similar articles
-
Psychotropic drug-induced falls in older people: a review of interventions aimed at reducing the problem.Drugs Aging. 2012 Jan 1;29(1):15-30. doi: 10.2165/11598420-000000000-00000. Drugs Aging. 2012. PMID: 22191720 Review.
-
Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.JBI Libr Syst Rev. 2009;7(13):492-582. doi: 10.11124/01938924-200907130-00001. JBI Libr Syst Rev. 2009. PMID: 27819974
-
Fall-Risk-Increasing Drugs: A Systematic Review and Meta-Analysis: II. Psychotropics.J Am Med Dir Assoc. 2018 Apr;19(4):371.e11-371.e17. doi: 10.1016/j.jamda.2017.12.098. J Am Med Dir Assoc. 2018. PMID: 29402652
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
Psychotropic medications in older adults: a review.Psychiatr Danub. 2016 Mar;28(1):13-24. Psychiatr Danub. 2016. PMID: 26938816 Review.
Cited by
-
Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries.BMC Geriatr. 2024 Mar 7;24(1):240. doi: 10.1186/s12877-024-04742-7. BMC Geriatr. 2024. PMID: 38454372 Free PMC article.
-
A longitudinal cohort study on dispensed analgesic and psychotropic medications in older adults before, during, and after the COVID-19 pandemic: the HUNT study.BMC Geriatr. 2025 Feb 7;25(1):85. doi: 10.1186/s12877-025-05745-8. BMC Geriatr. 2025. PMID: 39920618 Free PMC article.
-
An Updated Analysis of Psychotropic Medicine Utilisation in Older People in New Zealand from 2005 to 2019.Drugs Aging. 2022 Aug;39(8):657-669. doi: 10.1007/s40266-022-00965-8. Epub 2022 Jul 13. Drugs Aging. 2022. PMID: 35829958
-
The Prevention of Suicide in Older Military Veterans.Behav Sci (Basel). 2025 Mar 17;15(3):379. doi: 10.3390/bs15030379. Behav Sci (Basel). 2025. PMID: 40150273 Free PMC article. Review.
-
Influence of Ageing on the Pharmacodynamics and Pharmacokinetics of Chronically Administered Medicines in Geriatric Patients: A Review.Clin Pharmacokinet. 2025 Mar;64(3):335-367. doi: 10.1007/s40262-024-01466-0. Epub 2025 Jan 11. Clin Pharmacokinet. 2025. PMID: 39798015 Free PMC article. Review.
References
-
- National Institute for Health and Care Excellence (NICE) . First-Choice Antidepressant Use in Adults with Depression or Generalised Anxiety Disorder Key Therapeutic Topic [KTT8]. nice.org.uk/guidance/ktt8(2 January 2021, date last accessed).
-
- National Institute for Health and Care Excellence (NICE) . Antipsychotics in People Living with Dementia [KTT7]. https://www.nice.org.uk/advice/ktt7(2 January 2021, date last accessed).
-
- Brett J, Pearson S-A, Daniels B, Wylie CE, Buckley NA. A cross sectional study of psychotropic medicine use in Australia in 2018: a focus on polypharmacy. Br J Clin Pharmacol 2021; 87: 1369–77. - PubMed
-
- Percudani M, Barbui C, Fortino I, Petrovich L. Antidepressant drug prescribing among elderly subjects: a population-based study. Int J Geriatr Psychiatry 2005; 20: 113–8. - PubMed
-
- Dempsey O, Moore H. Psychotropic prescribing for older people in residential care in the UK, are guidelines being followed? Prim Care Community Psychiatry 2005; 10: 13–8.